Neurostimulation Devices | Market Insights | Europe (Supplemental) | 2024
Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on expanding into new indications, increasing the population treatable with these devices, although limited reimbursement and increasing competition from noninvasive alternatives will hinder the pace of market growth to some extent.
This Medtech 360 Report provides high-level market metrics for neurostimulation devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2032.
